MARIA COSIMINI: Open Payments
NPI 1699515536 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,724 in 147 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,148 · 2025 $3,724
Food & beverage: $3,544Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $499 |
| Janssen Biotech, Inc. | 20 | $484 |
| Galderma Laboratories, L.P. | 17 | $472 |
| UCB, Inc. | 14 | $426 |
| Regeneron Healthcare Solutions, Inc. | 11 | $404 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $300 |
| GENZYME CORPORATION | 8 | $179 |
| Botanix SB Inc | 2 | $129 |
| Organon LLC | 3 | $109 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $102 |
Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, RINVOQ, ILUMYA, SOFDRA, SKYRIZI.
Industry payments across CT — which companies pay providers there.
